OpenAI acquires Orchestra Bio
OpenAI is acquiring Orchestra Bio to bring AI powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
۱ دقیقه مطالعهمتن اصلی
OpenAI is acquiring Orchestra Bio to bring AI powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
منتشرشده در
OpenAI News
ادامه مطالعه



